IRulya Therapeutics Inc. IRLA · Insights

website

IRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled for...

Price33.775

Market Cap366.22 M

Float10.8 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro